Diagnostics & Imaging

Tempus ECG-MR

FDA-cleared ECG analysis that flags signs associated with moderate or severe mitral regurgitation.

The Signal

For eligible patients aged 65 and older, a flagged ECG can prompt further evaluation; it does not diagnose valve disease.

AI-driven triage and notification software for detecting acute abnormalities in medical imaging scans.

Care coordination platform using artificial intelligence to identify strokes and other vascular diseases.

AI-powered radiology solutions for detecting lung abnormalities and breast cancer on chest X-rays.

FDA-cleared digital pathology software utilizing artificial intelligence to assist pathologists in cancer detection.

Ambulatory cardiac monitoring service using wearable biosensors and cloud-based data analytics.

AI-powered pathology analysis tools for drug development and diagnostic accuracy in clinical trials.